Clinical Trial Update: Early Response to Interferon Combined Short-Term Nucleoside Analogue Therapy in HBeAg(+) Chronic Hepatitis B [NA]

View source ↗

Summary

This is a clinical trial update reporting on early response to interferon combined with short-term nucleoside analogue therapy in HBeAg-positive chronic hepatit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatitis B, Chronic | NA | Status: UNKNOWN